Abstract Library

#1805 Application of Parametric Contrast-Enhanced Ultrasound for Early Treatment Response Evaluation in Metastatic Hepatic Neuroendocrine Neoplasm

Introduction: Since shrinkage of lesions in patients with metastatic hepatic neuroendocrine neoplasm (MHNEN) receiving systemic therapy is rarely observed,limit of RECIST for evaluating treatment response gradually emerged.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Lin X

Authors: Lin X, Chen J, Xu M, Xie X, Zhang Y,

Keywords: neuroendocrine neoplasm,hepatic,parametric CEUS,early response evaluation.,

#1727 Ultrasonography Characteristics of Hepatic Neuroendocrine Neoplasm

Introduction: The incidence of hepatic neuroendocrine neoplasm (HNEN) is significantly increased in recent years.Lack of recognization usually lead to misdiagnosis.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Lin X

Authors: Lin X, Chen J, Xu M, Xie X, Zhang Y,

Keywords: neuroendocrine neoplasm,baseline ultrasound,contrast-enhanced ultrasound,hepatic,

#725 Contrast-Enhanced Ultrasonography (CEUS) Predicts the Effectiveness of Anti-Angiogenic Therapies in Patients with Liver Metastases from Neuroendocrine Tumors

Introduction: Liver metastases (LM) from neuroendocrine tumors (NETs) exhibit a typical hypervascular pattern in the arterial phase on CEUS, allowing for a differential diagnosis between NET and non-NET LM. Medical therapy includes agents acting on angiogenesis and vascularization which may result in a change in CEUS findings.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Di Sarno A

Authors: Di Sarno A, Del Prete M, Marotta V, De Stefano G, Marciello F,

Keywords: neuroendocrine tumor, liver metastases, CEUS, contrast enhancement, predictive factor of response,

#724 Contrast-Enhanced Ultrasonography (CEUS) Reliably Predicts Tumor Progression in Pancreatic Neuroendocrine Tumors

Introduction: Neuroendocrine tumors (NETs) exhibit a typical vascular pattern in the arterial phase on CEUS. The role of CEUS in the prognostic evaluation of pancreatic NET (pNET) has been poorly investigated.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author: Del Prete M

Authors: Del Prete M, Di Sarno A, Ramundo V, Marciello F, Marotta V,

Keywords: pancreatic neuroendocrine tumors, CEUS, contrast enhancement, prognosis,

#541 Contrast-Enhanced Ultrasound (CEUS) is a Helpful Tool to Predict the Effectiveness of Somatostatin Analogues in Patients with Liver Metastases From Neuroendocrine Tumors

Introduction: Contrast-enhanced ultrasonography (CEUS) allows characterization of the micro-vascularization of tumor lesions. Liver metastases (LM) from neuroendocrine tumors (NET) show a typical pattern on CEUS, consistent with a rapid, intense and homogeneous enhancement (hypervascular pattern) in the arterial phase.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Ramundo V, Faggiano A, De Stefano G, Marciello F, Marotta V,

Keywords: neuroendocrine tumor, liver metastases, CEUS, prognostic factors, tumor detection,